OFFERING A FAST, EFFICIENT AND COST EFFECTIVE SERVICE FOR PAEDIATRIC CLINICAL TRIALS IN RARE GENETIC DISORDERS THE COMPANY Myriad Trials was created to run clinical trials for children with rare genetic disorders in the independent sector. This means we can guarantee efficient and effective trials to allow ‘first-patient-in’ quickly. Our facilities are equipped to provide high-quality trials, and we are supported by an in-house team with over ten years of experience. We are building a portfolio of sites across the UK to provide the facilities where we can conduct natural history studies, phase 2/3 clinical trials, and N-of-one studies, as well as validate devices and tools in the trial setting. MELITA IRVING Myriad Trials is the brainchild of Melita Irving, a highly respected Clinical Geneticist with an impressive 24 years of experience. Her career, which began with paediatric training and culminated in the prestigious FRCPCH qualification, has been marked by numerous successful initiatives. Melita is a Fellow of the Royal College of Paediatrics and Child Health and has collaborated with renowned organizations such as BioMarin, QED/BridgeBio, and Ascendis, further solidifying her credibility and expertise in the field. Previously, Melita was a former President of the Medical Genetics section of the Royal Society of Medicine.
